Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Time in therapeutic range and risk of thromboembolism and bleeding in patients with a mechanical heart valve prosthesis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Impact of perioperative course during cardiac surgery on outcomes in patients 80 years and older

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Specialist training for cardiothoracic surgery in the Nordic countries

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The significance of bicuspid aortic valve after surgery for acute type A aortic dissection

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Malperfusion in acute type A aortic dissection: An update from the Nordic Consortium for Acute Type A Aortic Dissection

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: Oral anticoagulation with vitamin K antagonists is recommended after mechanical heart valve replacement. However, data regarding the association between the quality of vitamin K antagonist treatment and the risk of complications are sparse.

METHODS: Patients undergoing mechanical heart valve replacement (1997-2012) with available data on international normalized ratio values were identified in Danish registries. The quality of vitamin K antagonist treatment between discharge after valve replacement and 6 months postdischarge (ie, index) was assessed as time in therapeutic range (TTR) ≥70% or <70% reflecting the percentage of time in therapeutic international normalized ratio interval. Patients were followed from index until occurrence of an outcome of interest (ie, thromboembolism and bleeding), death, or end of study (December 31, 2012), whichever came first. The risk of outcomes according to quality of vitamin K antagonist treatment was estimated with multivariable Cox regression.

RESULTS: In total, 659 patients undergoing mechanical heart valve replacement were included in the study. Median number of international normalized ratio measurements in the 6-month period after surgery was 13 (interquartile range, 8-19). Median TTR was 54.9% (interquartile range, 39.0%-72.9%) and 29.1% of patients had a TTR ≥70%. Median follow-up was 6.1 years. The risk of thromboembolism was significantly lower in the group with TTR ≥70% compared with TTR <70% (hazard ratio, 0.44; 95% confidence interval, 0.22-0.85), whereas no significant difference concerning risk of bleeding among groups was found (hazard ratio, 0.63; 95% confidence interval 0.36-1.08).

CONCLUSIONS: In patients undergoing mechanical heart valve replacement, TTR <70% in the 6-month period after surgery was associated with an increased risk of thromboembolic events but not bleeding compared with TTR ≥70%.

Original languageEnglish
JournalJournal of Thoracic and Cardiovascular Surgery
Volume159
Issue number1
Pages (from-to)74-83.e4
ISSN0022-5223
DOIs
Publication statusPublished - 1 Jan 2020

    Research areas

  • epidemiology, mechanical heart valve prostheses, Nordic Medico-Statistical Committee, oral anticoagulation, time in therapeutic range, vitamin K antagonists

ID: 58229759